iShares Genomics Immunology And Healthcare ETF (IDNA) closed at $41.04 on October 22, 2026, down 3.9% from the previous close, on volume of 304,021 shares (30-day average 180,874).
Data as of October 22, 2026.
No press releases found.
No science background? AI does the lab work
Seeking Alpha News (Tue, 20-Oct 11:11 AM ET)
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
iShares Genomics Immunology And Healthcare ETF trades on the ARCA stock market under the symbol IDNA.
As of October 23, 2026, IDNA stock price declined to $40.69 with 10,273 million shares trading.
IDNA has a beta of 0.80, meaning it tends to be less sensitive to market movements. IDNA has a correlation of 0.13 to the broad based SPY ETF.
IDNA has a market cap of $317.38 million. This is considered a Small Cap stock.
In the last 3 years, IDNA traded as high as $43.44 and as low as $17.26.
IDNA has outperformed the market in the last year with a price return of +66.9% while the SPY ETF gained +15.1%. IDNA has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +25.6% and +0.7%, respectively, while the SPY returned +2.1% and -1.7%, respectively.
IDNA support price is $40.14 and resistance is $41.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IDNA shares will trade within this expected range on the day.
